BioMed Research International

Volume 2013 (2013), Article ID 181564, 8 pages

http://dx.doi.org/10.1155/2013/181564

Research Article

Spectrum of Bacterial Keratitis at a Tertiary Eye Care Centre in India

Jayaraman Kaliamurthy, Catti Muniswamy Kalavathy, Pragya Parmar, Christadas Arul Nelson Jesudasan, and Philip A. Thomas

Department of Ocular Microbiology, Institute of Ophthalmology, Joseph Eye Hospital, Trichy, Tamil Nadu 620001, India

Received 27 April 2013; Accepted 27 July 2013

Academic Editor: Vishal Jhanji

Copyright © 2013 Jayaraman Kaliamurthy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Aim. To report the aetiological spectrum and susceptibility patterns of bacteria isolated from patients with corneal ulceration. Method. The microbiological data of all patients with suspected infectious corneal ulceration who presented to the ocular microbiology service at this centre between 2005 and 2012 were reviewed retrospectively. Result. Microorganisms were recovered from 1665 (77%) of the 2170 ulcers. Bacterial isolates accounted for 1205 of the organisms isolated. The most common bacterial pathogens isolated were various species of Staphylococcus, representing 777 (64.5%), followed by Staphylococcus spp. (148; 12.3%) and Pseudomonas aeruginosa (117; 9.7%). High percentages of Gram-positive bacteria were susceptible to gatifloxacin (>94%), followed by ofloxacin and moxifloxacin. Almost 90% of Pseudomonas aeruginosa isolates were susceptible to ciprofloxacin and moxifloxacin. Sixty-two (44%) of 140 isolates of Streptococcus pneumoniae, 79 (14.8%) of 534 isolates of Staphylococcus epidermidis, and 33 (14%) of 234 isolates of Staphylococcus aureus were resistant to three or more antibiotics. Conclusion. Staphylococcus spp. were the most common bacterial pathogens isolated from patients with keratitis in this setting. High percentages of Gram-positive and Gram-negative bacteria were susceptible to gatifloxacin and moxifloxacin, respectively. Interestingly, a high percentage of Streptococcus pneumoniae isolates were found to be resistant to three or more antibiotics.

1. Introduction

Bacterial keratitis is a potentially devastating corneal infection due to the possibility of rapid progression; corneal destruction may be complete in 24–48 hours with some of the more virulent bacterial aetiological agents. The spectrum of bacterial corneal pathogens is largely dictated by the local microbial flora and also by geographic and climatic factors; these probably account for disparate rates of various pathogens reported in series from different localities [1, 2]. Species of high virulence, such as Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and even Neisseria meningitidis, have been reported [3]. Coagulase-negative staphylococci (CoNS) are also being increasingly reported as the cause of bacterial keratitis in various parts of the world [1, 4–6]. The number of multiresistant CoNS identified in patients with active ocular infection has also continued to increase in recent years [4, 7]. The visual prognosis after bacterial keratitis depends on the size, locality, and depth of the ulcer, as well as on the risk factors and the bacteria isolated [8].

Bacterial keratitis is an ophthalmic emergency that needs immediate institution of treatment. In the absence of laboratory diagnosis, the initial therapy is usually broad spectrum intensive treatment. Although empirically guided therapy may suffice in cases of keratitis caused by antibiotic-susceptible bacteria, there is a risk that resistant bacteria may result in unnecessarily poor visual outcome if the microbiological diagnosis is not made [9]. Specific therapy should be based on laboratory data which identify the causative agents and provide antibacterial susceptibility results [10]. Knowledge of the microbiological pattern of bacterial keratitis will be helpful for effective management of keratitis in situations where resources are limited. The spectrum of bacteria isolated from corneal ulceration and their susceptibility patterns are described in this paper.

2. Materials and Methods

The study was conducted with the approval of the Institutional Ethics Committee of the authors’ institution and was designed as a retrospective review of microbiological records of all patients with suspected infectious corneal ulceration who presented to the ocular microbiology service at Joseph Eye Hospital, Tiruchirappalli, Tamilnadu, southern India, between January 2005 and December 2012.

Standard microbiological investigations [11] had been performed on material obtained under topical anaesthesia (4% lignocaine hydrochloride) by scraping the base and edges of the ulcerated part of the cornea under the magnification of a slit lamp by an ophthalmologist using a sterile Kimura platinum spatula or a sterile Bard-Parker knife. Several scrapings had been performed to obtain adequate material for direct microscopy and culture.

For each patient, a portion of the corneal scrape material obtained had been used for direct microscopy (Gram-stained smear and lactophenol cotton blue-stained wet mount preparations), while the remaining material had also been inoculated directly onto the following media that support the growth of bacteria, fungi, and Acanthamoeba: sheep blood agar, Sabouraud dextrose agar and broth, and brain–heart infusion agar and broth. In addition, nonnutrient agar with Escherichia coli overlay had been used for clinically-suspected Acanthamoeba ulcers. Corneal scrapings had been inoculated onto plates of solid media by making rows of “C” streaks (two rows were made from each scraping). Brain–heart infusion agar and broth and blood agar were incubated at 37°C and were examined daily for 7 days. Sabouraud dextrose agar and the broth were incubated at room temperature (28 to 30°C) and were examined daily for 4 weeks.

Bacterial growth obtained had been deemed significant if at least one of the following criteria had been fulfilled:

(a)the same bacterium was isolated on more than one solid medium; (b)the bacterium isolated in culture exhibited a morphology consistent with direct microscopic findings; or(c)the same organism was grown from one liquid medium and a solid medium

The bacteria isolated had been identified by standard biochemical test methods [12] and tested for their susceptibility in vitro to amikacin (30 μg), chloramphenicol (30 μg), ciprofloxacin (5 μg), gatifloxacin (5 μg), gentamicin (10 μg), moxifloxacin (5 μg), ofloxacin (5 μg), and tobramycin (10 μg) by the standard agar disc-diffusion method (Kirby-Bauer) using the discs obtained from Hi-Media, Mumbai, India and Mueller Hinton agar.

3. Results

Two thousand one hundred and seventy patients corneal ulcers had been scraped for microbiological investigations over the period of eight years from January 2005 to December 2012. The mean age of the patients was years. Of the 2170 patients, 1274 (58.7%) were males, and 896 (41.3%) were females. Microorganisms (bacteria, fungi, and Acanthamoeba) were grown from 1665 (77%) of the 2170 ulcers (Table 1). Sixty-four percent of patients with culture-proven microbial keratitis had reported antecedent ocular trauma by animate and inanimate objects (Table 2). A detailed classification of the reported predisposing factors and risk factors stratified according to the microbiological agent isolated is provided in Table 2.

Table 1: Aetiological spectrum of microbial keratitis over an 8-year period (2005–2012) at a tertiary eye care facility in India.

Year
Bacterial only
Fungal only
Mixed (bacterial + fungal)
Others*
No growth
Total

2005
95
89
19
5
120
328

2006
86
80
23
0
119
308

2007
109
105
38
2
72
326

2008
108
44
36
6
63
257

2009
115
64
44
1
56
280

2010
88
51
69
0
27
235

2011
121
35
56
4
26
242

2012
85
25
58
4
22
194

Total
807⁺
493
343⁺⁺
22⁺⁺⁺
505
2170

Acanthamoeba sp. & Nocardia sp.

+In some patients, more than one bacteria was isolated.

++In some patients, more than one bacteria was isolated in addition to fungi.

+++Nocardia accounted for 13 isolates.

Table 2: Putative risk factors for culture positive microbial keratitis (total number of culture proven microbial keratitis = 1665).

Total
Results of culture

Bacterial only
Fungal only
Mixed (bacterial + fungal)
Others*
No growth

Number of patients
2170
807
493
343
22
505

Trauma
1065 (64)

Mud, dust, and soil
379 (35.6)
125
114
72
2
66

Leaf & vegetable matter
337 (31.6)
75
121
53
3
85

Stick
134 (12.6)
47
36
12
1
38

Stone
59 (5.5)
22
12
8
1
16

Insect
50 (4.7)
25
14
6
0
5

Finger nail
43 (4.0)
16
12
4
1
10

Wood piece
20 (1.9)
5
6
3
1
5

Metal (iron)
19 (1.8)
6
2
3
0
8

Animal tail, horn
9 (0.8)
3
3
2
1
0

Glass piece
9 (0.8)
1
1
1
0
6

Ball
6 (0.6)
1
1
1
0
3

Contact lens wear
16 (1.0)
6
0
2
0
8

Use of eye drops (antibiotics)
322 (19.3)
84
99
33
2
104

Use of traditional eye medicine (oil, leaf juice, milk, etc.)
282 (16.9)
64
135
81
0
2

The mean number of corneal ulcers scraped per year from 2005 through 2012 was . During this period, there were 1205 bacterial isolates from the 2170 corneal ulcers that had been scraped; 807 bacterial isolates were obtained as the sole isolate from the scraped ulcer. In 343 patients, the scraped ulcer yielded significant growth of more than one species of bacteria or growth of bacteria along with fungus (“mixed growth”) (Table 1).

Gram-stained smears of corneal scrapings from 23 of the 807 patients (2.8%) for whom culture had yielded only a single bacterial species had not revealed presence of bacteria. Similarly, Gram-stained smears of corneal scrapings from 12 of 343 patients (3.5%) for whom culture had yielded multiple microorganisms (“mixed growth”) also had not shown presence of bacteria. In contrast, Gram-stained smears of corneal scrapings from 123 of 505 patients (24.4%) for whom there had not been any growth in culture revealed significant numbers of Gram-positive cocci or Gram-negative bacilli.

There were 992 (82%) isolates of Gram-positive bacteria and 213 (18%) isolates of Gram-negative bacteria in culture (Table 3). The most common bacterial pathogens isolated were various species of Staphylococcus, accounting for 777 (64.5%) of all positive bacterial cultures, followed by Streptococcus spp. (148; 12.3%), Pseudomonas aeruginosa (117; 9.7%), Bacillus sp. (63; 5.2%), Acinetobacter sp. (56; 4.6%)), and Aeromonas sp. (18; 1.49%). Enterobacter sp., Klebsiella pneumoniae, Serratia marcescens, and Flavobacterium sp. were the least frequently isolated organisms in the series (Table 3).

Table 3: Bacterial isolates recovered from patients with corneal ulceration over an 8-year period (2005–2012) at a tertiary eye care facility in India.

Bacterium
2005

n (%)
2006

n (%)
2007

n (%)
2008

n (%)
2009

n (%)
2010

n (%)
2011

n (%)
2012

n (%)
Total

n (%)

Staphylococcus epidermidis
48 (37.5)*
38 (31.7)*
73 (43.7)*
81 (54)*
75 (46.8)*
87 (51.8)*
85 (45.4)*
47 (37.6)*
534 (44)

Staphylococcus aureus
03
10
26
21
28
35
61
51
235 (19.5)

Staphylococcus saprophyticus
00
04
00
01
02
0
1
0
8 (0.6)

Staphylococci total
51
52
99
103
105
122
147
98
777 (64.5)

Streptococcus pneumoniae
27
24
27
13
14
14
12
9
140 (11.6)

Viridans streptococci
0
0
0
0
08
0
0
0
8 (0.6)

Streptococci total
27
24
27
13
22
14
12
9
148 (12.3)

Total Gram-positive cocci total
78
76
126
116
127
136
159
107
925

Bacillus species
21
13
07
05
04
3
2
8
63 (5.2)

Corynebacterium diphtheriae.
00
00
03
00
00
1
0
0
4 (0.3)

Gram-positive bacilli total
21
13
10
5
4
4
2
8
67

Gram positive organisms total
99
89
136
121
131
140
161
115
992

Pseudomonas aeruginosa
15
23
20
17
10
18
11
3
117 (9.7)

Acinetobacter species
10
08
04
05
11
5
9
4
56 (4.6)

Aeromonas species
02
00
04
01
04
2
4
1
18 (1.49)

Enterobacter species
0
0
02
04
02
0
0
0
08 (0.6)

Klebsiella pneumoniae
01
00
01
02
02
3
2
1
12 (0.99)

Serratia species
01
00
00
00
00
0
0
0
01 (0.08)

Flavobacterium species
0
0
0
0
0
0
0
1
01 (0.08)

Gram negative total
29
31
31
29
29
28
26
10
213

Total isolates
128
120
167
150
160
168
187
125
1205

n: number of isolates; %: corresponding per cent; *% in respective year.

Table 4 summarises susceptibility profile of the most frequent bacterial isolates recovered. Only the susceptibility test results for amikacin, chloramphenicol, ciprofloxacin, gentamicin, gatifloxacin, moxifloxacin, ofloxacin, and tobramycin were considered for analysis as they are routinely used for ocular infections in the region. More than 94% of Gram-positive bacteria were found susceptible to gatifloxacin, while a high percentage were susceptible to ofloxacin and moxifloxacin. Almost 90% of Pseudomonas aeruginosa isolates were susceptible to amikacin and gentamicin, while 83% were susceptible to ciprofloxacin and 82% to moxifloxacin.

Table 4: Frequent bacterial isolates and percentage of strains susceptible to antibacterial agents in bacterial keratitis at a tertiary eye care facility in India (2005–2012).

Organism (number of isolates)
Antibacterial agents

AK

n (%)
C

n (%)
CF

n (%)
G

n (%)
GF

n (%)
MO*  

n (%)
OF

n (%)
TB

n (%)

Staphylococcus epidermidis (534)
477 (89.3)
429 (80.3)
376 (70.4)
436 (81.6)
501 (93.8)
312¹ (69.6)
430 (80.5)
426 (79.8)

Staphylococcus aureus (235)
224 (95.3)
199 (84.7)
180 (76.6)
199 (84.7)
230 (97.9)
163² (73.4)
195 (83.0)
203 (86.4)

Streptococcus pneumoniae (140)
53 (37.8)
115 (82.1)
106 (75.7)
43 (30.7)
133 (95)
77³ (86.5)
121 (86.4)
60 (42.8)

Bacillus spp. (63)
59 (93.6)
57 (90.5)
47 (74.6)
58 (92.0)
61 (96.8)
22⁴ (75.9)
62 (98.4)
59 (93.6)

Pseudomonas aeruginosa (117)
105 (89.7)
47 (40.2)
97 (82.9)
105 (89.7)
86 (73.5)
65⁵ (82.3)
86 (73.5)
86 (73.5)

Acinetobacter sp. (56)
52 (92.8)
46 (82.14)
48 (85.7)
50 (89.28)
52 (92.8)
35⁶ (92.1)
43 (76.8)
43 (76.8)

Due to unavailability of moxifloxacin discs in the year 2005, the total numbers of isolates tested against moxifloxacin are different from the numbers of isolates tested against other antibiotics. Hence, the total number of isolates tested for moxifloxacin = ¹448; ²222; ³89; ⁴29; ⁵79; and ⁶38.

n: number of isolates susceptible to the antibiotic. %: corresponding per cent.

AK: amikacin; C: chloramphenicol; CF: ciprofloxacin; G: gentamicin; GF: gatifloxacin; OF: ofloxacin; MO: moxifloxacin; and TB: tobramycin.

When we analysed patterns of resistance to multiple antibacterials, it was found that 62 of 140 (44%) strains of S. pneumoniae, 79 of 534 (14.8%) S. epidermidis strains, 33 of 235 (14%) S. aureus strains, 8 of 117 (6.8) Ps. aeruginosa strains, 4 of 63 (6%) strains of Bacillus sp., and 3 of 56 (5%) strains of Acinetobacter sp. were resistant to three or more antibiotics. Interestingly, only one isolate of Ps. aeruginosa exhibited resistance to all the 8 test antibacterials (Table 5) although none of the other bacterial isolates showed resistance to all the eight antibacterials.

Table 5: Resistance patterns of frequent bacterial isolates recovered from corneal ulceration over an eight-year period (2005–2012) at a tertiary eye care facility in India.

Resistance to
Organism

S. epidermidis  

n (%)
S. aureus  

n (%)
S. pneumoniae  

n (%)
Bacillus spp.

n (%)
Ps. aeruginosa  

n (%)
Acinetobacter sp.  

n (%)

8 antibiotics
0
0
0
0
1 (0.8)
0

7 antibiotics
1 (0.2)
1 (0.4)
0
0
0
0

6 antibiotics
4 (0.7)
1 (0.4)
1 (0.7)
0
2 (1.7)
0

5 antibiotics
13 (2.4)
2 (0.8)
1 (0.7)
0
0
1 (0.8)

4 antibiotics
22 (4.1)
6 (2.5)
15 (10.7)
1 (1.6)
3 (2.6)
0

3 antibiotics
39 (7.3)
23 (9.8)
45 (32.1)
3 (4.8)
2 (1.7)
2 (1.7)

2 antibiotics
83 (15.5)
29 (12.3)
39 (27.8)
6 (9.5)
19 (16.2)
3 (5.3)

1 antibiotic
128 (23.9)
48 (20.4)
21 (15)
7 (11.1)
63 (53.8)
11 (19.6)

0 antibiotic
244 (45.7)
125 (53.2)
18 (12.8)
46 (73)
27 (23)
39 (69.6)

Total isolates tested
534
235
140
63
117
56

n: number of isolates that showed resistance, %: corresponding per cent.

Selected antibiotics: amikacin, chloramphenicol, ciprofloxacin, gentamicin, gatifloxacin, moxifloxacin, ofloxacin, tobramycin.

4. Discussion

Bacterial keratitis is a potentially devastating ocular infection that may occur when the corneal epithelial barrier is compromised due to injury or trauma, leading to ulceration and infiltration of inflammatory cells [13]. Infection largely involves Gram-positive S. aureus, S. epidermidis, and several Streptococcus and Bacillus spp., as well as Gram-negative bacteria such as Ps. aeruginosa. Immediate diagnosis and treatment are important to avoid vision-threatening outcomes, including corneal scarring or perforation.

In the present series, we found that trauma (64%) is the most common predisposing factor in our patients, a figure similar to that reported in Iran [14], Qatar [15], and Sudan [16]. Mud, dust, and soil were the most frequently reported (35.6%) followed by leaf & vegetable matter (31.6%). More or less, equal proportions of the patients in the present study reported trauma by mud and dust particles and vegetable material. Possibly during the windy season, the injury by dust particles might have been more prevalent whereas injury by vegetable matter possibly was more common during the peak season of agricultural work in this area.

Wearing of contact lenses has been a major risk factor for bacterial keratitis in reports from Saudi Arabia, France, and Australia [3, 6, 17, 18]. In contrast to the reports cited above, contact lens wear was reported by only 12 (1%) patients in the present series.

In the present series, microorganisms were recovered in culture from 77% of the corneal ulcers scraped. This rate of culture positivity is comparable to the 40% to 73% culture positivity rates reported in earlier studies from Australia [19], France [18], and other parts of the world [20–23].

The ability of an organism to adhere to the edge or base of an epithelial defect signatures its pathogenicity, since such an organism has the ability to invade the stroma despite adequate host defenses [24]; S. aureus, S. pneumonia, and Ps. aeruginosa are examples of bacteria with this invasive potential [25, 26]. In the present series, Gram-positive cocci accounted for 925 of 1205 (77%) bacterial isolates. This result is similar to the 69.1% [27] and 65.65% [2] reported by other Indian investigators. In other countries, Bourcier et al. [18] and Green et al. [20] reported 83% of corneal infections to be due to Gram-positive bacteria.

The predominant Gram-positive bacterial species isolated was S. epidermidis (44%). In one study in Switzerland, the most commonly isolated bacterium, S. epidermidis, accounted for 40% of isolate [3]. Earlier studies from India [5, 27–29], Australia [6], USA, Israel, Canada, France, and New Zealand [18, 30–33] also reported S. epidermidis or coagulase-negative staphylococci (CoNS) to be the predominant isolate. Ly et al. [6] reported that 38% of isolates from corneal ulcers were CoNS. Butler et al. [19] reported that CoNS accounted for 23% of isolates and was the most frequent isolate recovered from corneal ulcers of elderly patients in Australia. Thus, it appears that S. epidermidis continues to be a very important bacterial cause of keratitis.

Only 12.3% of isolates were streptococci in our study. This is in contrast to earlier results from India [2, 34] and other developing countries such as Bangladesh and Saudi Arabia, where S. pneumoniae was the most common organism isolated in bacterial keratitis [35, 36]. Interestingly, in one report from Australia, only 8% of the isolates were streptococci [6]. In developing countries, the prevalence of streptococci in corneal abscesses has been linked to coexisting lacrimal drainage obstruction [6, 37]. In addition, the aetiology of the corneal ulcers may vary significantly from region to region and between rural and urban patients. In the present study and also in the studies mentioned above, the pool of patients was not analysed to differentiate rural and urban patients.

In studies from South Florida and Hong Kong, Ps. aeruginosa was the most common organism isolated [38, 39], whereas Ps. aeruginosa accounted for only 9.7% of the isolates in our study. Our finding also differ from those of other investigators in India [29], Malaysia [40], and Beijing in China [41]. These differences may be due to regional climatic influences, number of contact lens-related keratitis cases, or the severity of cases included in each study.

Antibiotic resistance among ocular pathogens is increasing in parallel with the increase seen among systemic pathogens and likewise may have serious consequences such as development of sight-threatening complications of keratitis, endophthalmitis, orbital cellulitis, or panophthalmitis [42–44]. In the present series, only 70% to 76% of Gram-positive organisms (Staphylococcus spp. and S. pneumoniae) were susceptible to ciprofloxacin; of these, a comparatively low percentage of S. epidermidis isolates were susceptible to ciprofloxacin. This is consistent with an earlier report from our centre [45]. Similarly, 69.6% of S. epidermidis and 73.4% of S. aureus isolates were susceptible to moxifloxacin, the 4th generation fluoroquinolone, whereas 86.5% of S. pneumoniae was susceptible to moxifloxacin. However, 94% to 98% of staphylococci and 95% S. pneumoniae were susceptible to gatifloxacin. These data are consistent with those reported in earlier studies [46, 47] wherein 80% of CoNS were found to be susceptible to newer-generation fluoroquinolones. Jhanji et al. [48], from India, reported a case of keratitis due to CoNS where the isolated bacterium was found to be resistant to moxifloxacin, gatifloxacin, ciprofloxacin, and cefazolin in vitro and also clinically resistant to moxifloxacin. It is inferred from the present study that among the fluoroquinolones tested, gatifloxacin and ofloxacin exhibited the lowest rates of resistance, and hence, gatifloxacin or ofloxacin can be recommended as first-line therapy for bacterial keratitis due to Gram-positive organisms.

Parmar et al. [45] reported that corneal ulcer healing rates with gatifloxacin were significantly higher in infections caused by Gram-positive pathogens than in those caused by Gram-negative pathogens, suggesting that gatifloxacin may be a preferred (albeit off-label) alternative to ciprofloxacin as first-line monotherapy in bacterial keratitis. The older fluoroquinolones, such as ofloxacin, ciprofloxacin, and levofloxacin, preferentially inhibit topoisomerase IV of Gram-positive bacteria, whereas the newer fluoroquinolones, such as moxifloxacin, gatifloxacin, and besifloxacin, exhibit more balanced inhibition of both DNA gyrase and topoisomerase IV [49, 50]. These newer fluoroquinolones have structural features that confer less resistance potential than their fluoroquinolone predecessors, as well as increase ocular tissue concentrations relative to organism MIC values [49, 51, 52]. Gatifloxacin and moxifloxacin are both 8-methoxy fluoroquinolones, which are less prone to resistance developing from single-step mutations, and have been shown to remain potent even in the presence of single-step resistance mutations in staphylococcal and streptococcal strains [51].

In contrast to the susceptibility results obtained for Gram-positive organisms, very high percentages of Ps. aeruginosa isolated were susceptible to amikacin (89.7%), gentamicin (89.7%), ciprofloxacin (82.9%), and moxifloxacin (82.3%) and lower percentages to gatifloxacin (73.5%), tobramycin (73.5%), and ofloxacin (73.5%). The percentage of ocular Ps. aeruginosa isolates exhibiting resistance to gatifloxacin was reported to have increased from 13.2% in a European surveillance study conducted in 2002-2003 [53]. The percentage of P. aeruginosa isolates showing resistance to ciprofloxacin increased from less than 1.0% of isolates obtained from 1991 to 1994 to 4.4% of those obtained from 1995 to 1998 [54, 55] and to 29% of those obtained from 2002 to 2003 [46]. Moss et al. [47] reported that 100% of their Gram-positive and Gram-negative isolates were susceptible to moxifloxacin and gatifloxacin; however, these workers recovered the isolates from the normal flora of the eyes before intravitreal injection.

In the present series, only 40% of Ps. aeruginosa isolate was susceptible to chloramphenicol. Ly et al. [6] reported that 100% of Ps. aeruginosa isolates were resistant to chloramphenicol. These results indicate that chloramphenicol should not be used routinely as the topical antibiotic of choice for corneal infection in India, a view supported by studies in Australia, Singapore, and London [6, 56, 57].

It must be noted that the conventional Kirby-Bauer disc diffusion method of in vitro antibacterial susceptibility testing may not directly apply to corneal pathogens, since the ocular antibacterial level achievable by topical administration may be considerably higher than the level attained in the ocular tissue by systemic administration, and the levels attained by topical administration may be less than the serum level of antibacterials [27]. Indeed, there have been many studies that have reported susceptible and resistant patterns of corneal pathogens based on conventional in vitro antibacterial susceptibility testing [4, 27, 47, 58–60], and these in vitro susceptible and resistant patterns have successfully guided in vivo treatment by these antibacterials [45, 61–64]. These results provide information that allows a clinician to make rationale choice when deciding on a primary treatment regimen which provides broad coverage for common corneal pathogens.

Table 5 shows the number and corresponding percentages of frequently isolated bacterial species that were resistant to multiple antibiotics. On the whole, 44% of S. pneumoniae, 15% of S. epidermidis, 14% of S. aureus, 7% of Ps. aeruginosa, and 6% of Bacillus sp. isolates were resistant to ≥3 of 8 antibacterials tested. Only 1 isolate of Ps. aeruginosa was resistant to all the eight antibacterials, and none of the other bacterial isolates showed resistance to all the eight antibacterials. However, certain S. epidermidis strains exhibited resistance to from 3 to 7 antibacterials. Recently, Moss et al. [47] reported that 20 of the 59 (34%) of the CoNS isolates cultured from 18 eyes were resistant to ≥5 of the 14 antibiotics tested. Pinna et al. [4] conducted a retrospective review (1995 to 1996) that identified 55 clinically significant strains of CoNS showing a varied spectrum of resistance patterns. One study [65] reported resistance to two or more antibiotics in 25% of the staphylococcal isolates from patients with chronic blepharitis. The current study showed that a higher proportion of S. pneumoniae isolates, followed by S. epidermidis and S. aureus, was resistant to multiple antibacterials. Miller et al. [66] found increased in vitro resistance to gatifloxacin and moxifloxacin, as well as to older fluoroquinolones, among CoNS endophthalmitis isolates recovered between 1990 and 2004. Agarwal et al. [67] reported patterns of increasing resistance of ocular bacterial isolates to moxifloxacin, gatifloxacin, and tobramycin in the subsequent years (2006 and 2007). Recently, there have also been reports of clonal spread of super bugs such as S. pneumoniae 19A, a highly resistant strain that has emerged in the microbiological wake left by widespread use of pneumococcal vaccines [68]. Resistance to multiple antibiotics might possibly represent a response to prolonged treatment [4]. This is of concern because the spread of such strains in hospitals could be alarming in immunocompromised patients. It is recommended to perform antibiotic susceptibility testing in all cases of clinically significant ocular infections caused by these organisms.

Microbial resistance to antibiotic agents is becoming increasingly prevalent in ocular infections [69]. The past 2 decades have witnessed changes in antibiotic susceptibility patterns on a worldwide basis. Guidelines that have been developed to help slow the escalation of systemic antibiotic resistance and encourage prudent use of antibiotic agents also apply to the management of ocular infections. Clinicians should prescribe antibiotic agents only when clearly indicated and should order susceptibility testing whenever possible to prescribe the most appropriate agent [69]. The excessive use of antibiotic agents is a primary cause of resistance. In addition, physicians should select agents that have rapid bactericidal activity, high attainable concentrations at the site of infection compared with the organism MIC, a relatively low incidence of antibacterial resistance, and a broad spectrum of activity.

Conflict of Interests

The authors have no conflict of interests to declare.

References

A. K. Leck, P. A. Thomas, M. Hagan et al., “Aetiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis,” The British Journal of Ophthalmology, vol. 86, no. 11, pp. 1211–1215, 2002.

M. J. Bharathi, R. Ramakrishnan, S. Vasu, R. Meenakshi, and R. Palaniappan, “In-vitro efficacy of antibacterials against bacterial isolates from corneal ulcers,” Indian Journal of Ophthalmology, vol. 50, no. 2, pp. 109–114, 2002.

F. Schaefer, O. Bruttin, L. Zografos, and Y. Guex-Crosier, “Bacterial keratitis: a prospective clinical and microbiological study,” The British Journal of Ophthalmology, vol. 85, no. 7, pp. 842–847, 2001.

A. Pinna, S. Zanetti, M. Sotgiu, L. A. Sechi, G. Fadda, and F. Carta, “Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections,” The British Journal of Ophthalmology, vol. 83, no. 7, pp. 771–773, 1999.

P. Manikandan, M. Bhaskar, R. Revathy, R. K. John, K. Narendran, and V. Narendran, “Speciation of coagulase negative Staphylococcus causing bacterial keratitis,” Indian Journal of Ophthalmology, vol. 53, no. 1, pp. 59–60, 2005.

C. N. Ly, J. N. Pham, P. R. Badenoch et al., “Bacteria commonly isolated from keratitis specimens retain antibiotic susceptibility to fluoroquinolones and gentamicin plus cephalothin,” Clinical and Experimental Ophthalmology, vol. 34, no. 1, pp. 44–50, 2006.

J. F. John and A. M. Harvin, “History and evolution of antibiotic resistance in coagulase-negative staphylococci: susceptibility profiles of new anti-staphylococcal agents,” Therapeutics and Clinical Risk Management, vol. 3, no. 6, pp. 1143–1152, 2007.

O. D. Schein, P. O. Buehler, J. F. Stamler, D. D. Verdier, and J. Katz, “The impact of overnight wear on the risk of contact lens-associated ulcerative keratitis,” Archives of Ophthalmology, vol. 112, no. 2, pp. 186–190, 1994.

M. H. Goldstein, R. P. Kowalski, and Y. J. Gordon, “Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review,” Ophthalmology, vol. 106, no. 7, pp. 1313–1318, 1999.

S. Smitha, P. Lalitha, V. N. Prajna, et al., “Susceptibility trends of Pseudomonas species from corneal ulcers,” Indian Journal of Medical Microbiology, vol. 23, no. 3, pp. 168–171, 2005.

K. R. Wilhelmus, “Bacterial keratitis,” in Ocular Infection and Immunity, J. S. Pepose, G. N. Holland, and K. R. Wilhelmus, Eds., pp. 970–1031, Mosby, St. Louis, Mo, USA, 1996.

G. I. Barrow and R. K. A. Feltham, Cowan and Steel's Manual for the Identification of Medical Bacteria, Cambridge University Press, Cambridge, UK, 3rd edition, 1993.

G. Pachigolla, P. Blomquist, and H. D. Cavanagh, “Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in North Texas,” Eye and Contact Lens, vol. 33, no. 1, pp. 45–49, 2007.

M. R. Shoja and M. Manaviat, “Epidemiology and outcome of corneal ulcers in Yazd Shahid Sadoughi hospital,” Acta Medica Iranica, vol. 42, no. 2, pp. 136–141, 2004.

F. A. Muhsin Warid, F. A. Mansouri, and O. A. Qahtani, “Bacterial keratitis predisposing factors, clinical and microbiological review of 70 cases,” The Middle East Journal of Emergency Medicine, vol. 5, no. 1, 2005.

H. Bataineh, Q. Hammory, and A. Khatatba, “Bacterial keratitis: risk factors and causative agents,” Sudan Journal of Medical Science, vol. 3, no. 1, 2008.

K. F. Tabbara, H. F. El-Sheikh, and B. Aabed, “Extended wear contact lens related bacterial keratitis,” The British Journal of Ophthalmology, vol. 84, no. 3, pp. 327–328, 2000.

T. Bourcier, F. Thomas, V. Borderie, C. Chaumeil, and L. Laroche, “Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases,” The British Journal of Ophthalmology, vol. 87, no. 7, pp. 834–838, 2003.

T. K. Butler, N. A. Spencer, C. C. K. Chan, J. S. Gilhotra, and K. McClellan, “Infective keratitis in older patients: a 4 year review, 1998–2002,” The British Journal of Ophthalmology, vol. 89, no. 5, pp. 591–596, 2005.

M. D. Green, A. J. G. Apel, T. Naduvilath, and F. J. Stapleton, “Clinical outcomes of keratitis,” Clinical and Experimental Ophthalmology, vol. 35, no. 5, pp. 421–426, 2007.

P. Asbell and S. Stenson, “Ulcerative keratitis. Survey of 30 years' laboratory experience,” Archives of Ophthalmology, vol. 100, no. 1, pp. 77–80, 1982.

L. R. Groden, J. Rodnite, J. H. Brinser, and G. I. Genvert, “Acridine orange and Gram stains in infectious keratitis,” Cornea, vol. 9, no. 2, pp. 122–124, 1990.

J. Diamond, J. Leeming, G. Coombs et al., “Corneal biopsy with tissue micro-homogenisation for isolation of organisms in bacterial keratitis,” Eye, vol. 13, no. 4, pp. 545–549, 1999.

R. W. Synder and R. A. Hyndiuk, “Mechanisms of bacterialinvasion of the cornea,” in Duane's Foundations of Clinical Ophthalmology, W. Tasman and E. A. Jaeger, Eds., pp. 11–44, J B Lippincott, Philadelphia, Pa, USA, 1990.

R. Reichert and G. Stern, “Quantitative adherence of bacteria to human corneal epithelial cells,” Archives of Ophthalmology, vol. 102, no. 9, pp. 1394–1395, 1984.

N. Panjwani, B. Clark, M. Cohen, M. Barza, and J. Baum, “Differential binding of P. aeruginosa and S. aureus to corneal epithelium in culture,” Investigative Ophthalmology and Visual Science, vol. 31, no. 4, pp. 696–701, 1990.

S. Sharma, D. Y. Kunimoto, P. Garg, and G. N. Rao, “Trends in antibiotic resistance of corneal pathogens—part I. An analysis of commonly used ocular antibiotics,” Indian Journal of Ophthalmology, vol. 47, no. 2, pp. 95–100, 1999.

R. B. Vajpayee, T. Dada, R. Saxena et al., “Study of the first contact management profile of cases of infectious keratitis: a hospital-based study,” Cornea, vol. 19, no. 1, pp. 52–56, 2000.

G. Singh, M. Palanisamy, B. Madhavan et al., “Multivariate analysis of childhood microbial keratitis in South India,” Annals of the Academy of Medicine, vol. 35, no. 3, pp. 185–189, 2006.

A. I. Miedziak, M. R. Miller, C. J. Rapuano, P. R. Laibson, and E. J. Cohen, “Risk factors in microbial keratitis leading to penetrating keratoplasty,” Ophthalmology, vol. 106, no. 6, pp. 1166–1170, 1999.

E. Mezer, Y. A. Gelfand, R. Lotan, A. Tamir, and B. Miller, “Bacteriological profile of ophthalmic infections in an Israeli hospital,” European Journal of Ophthalmology, vol. 9, no. 2, pp. 120–124, 1999.

J. Cheung and A. R. Slomovic, “Microbial etiology and predisposing factors among patients hospitalized for corneal ulceration,” Canadian Journal of Ophthalmology, vol. 30, no. 5, pp. 251–255, 1995.

T. Wong, S. Ormonde, G. Gamble, and C. N. J. McGhee, “Severe infective keratitis leading to hospital admission in New Zealand,” The British Journal of Ophthalmology, vol. 87, no. 9, pp. 1103–1108, 2003.

M. Srinivasan, C. A. Gonzales, C. George et al., “Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India,” The British Journal of Ophthalmology, vol. 81, no. 11, pp. 965–971, 1997.

G. Williams, F. Billson, R. Husain, S. A. Howlader, N. Islam, and K. McClellan, “Microbiological diagnosis of suppurative keratitis in Bangladesh,” The British Journal of Ophthalmology, vol. 71, no. 4, pp. 315–321, 1987.

S. A. F. Al-Hazzaa and K. F. Tabbara, “Bacterial keratitis after penetrating keratoplasty,” Ophthalmology, vol. 95, no. 11, pp. 1504–1508, 1988.

M. K. Aasuri, M. K. Reddy, S. Sharma, and G. N. Rao, “Co-occurrence of pneumococcal keratitis and dacryocystitis,” Cornea, vol. 18, no. 3, pp. 273–276, 1999.

T. J. Liesegang and R. K. Forster, “Spectrum of microbial keratitis in South Florida,” American Journal of Ophthalmology, vol. 90, no. 1, pp. 38–47, 1980.

E. Houang, D. Lam, D. Fan, and D. Seal, “Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 4, pp. 361–367, 2001.

S. H. Hooi and S. T. Hooi, “Culture-proven bacterial keratitis in a Malaysian General hospital,” Medical Journal of Malaysia, vol. 60, no. 5, pp. 614–623, 2005.

X. Sun, S. Deng, R. Li et al., “Distribution and shifting trends of bacterial keratitis in North China (1989–98),” The British Journal of Ophthalmology, vol. 88, no. 2, pp. 165–166, 2004.

P. A. Asbell, K. A. Colby, S. Deng et al., “Ocular TRUST: nationwide antimicrobial ausceptibility patterns in ocular isolates,” American Journal of Ophthalmology, vol. 145, no. 6, pp. 951–958, 2008.

G. Høvding, “Acute bacterial conjunctivitis,” Acta Ophthalmologica, vol. 86, no. 1, pp. 5–17, 2008.

A. Sheikh and B. Hurwitz, “Antibiotics versus placebo for acute bacterial conjunctivitis,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD001211, 2006.

P. Parmar, A. Salman, C. M. Kalavathy, J. Kaliamurthy, P. A. Thomas, and C. A. N. Jesudasan, “Microbial keratitis at extremes of age,” Cornea, vol. 25, no. 2, pp. 153–158, 2006.

J. Kaliamurthy, C. A. Nelson Jesudasan, P. Geraldine, P. Parmar, C. M. Kalavathy, and P. A. Thomas, “Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics,” Ophthalmic Research, vol. 37, no. 3, pp. 117–122, 2005.

J. M. Moss, S. R. Sanislo, and C. N. Ta, “Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections,” Ophthalmology, vol. 117, no. 11, pp. 2141–2145, 2010.

V. Jhanji, N. Sharma, G. Satpathy, and J. Titiyal, “Fourth-generation fluoroquinolone-resistant bacterial keratitis,” Journal of Cataract and Refractive Surgery, vol. 33, no. 8, pp. 1488–1489, 2007.

J. M. Blondeau, G. Hansen, K. Metzler, and P. Hedlin, “The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration,” Journal of Chemotherapy, vol. 16, no. 3, pp. 1–19, 2004.

E. Cambau, S. Matrat, X. S. Pan et al., “Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli,” Journal of Antimicrobial Chemotherapy, vol. 63, no. 3, pp. 443–450, 2009.

D. G. Hwang, “Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones,” Survey of Ophthalmology, vol. 49, no. 2, pp. S79–S83, 2004.

C. K. Hesje, G. S. Tillotson, and J. M. Blondeau, “MICs, MPCs and PK/PDs: a match (sometimes) made in hosts,” Expert Reviews in Respiratory Medicine, vol. 1, no. 1, pp. 7–16, 2007.

I. Morrissey, R. Burnett, L. Viljoen, and M. Robbins, “Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002,” The Journal of Infection, vol. 49, no. 2, pp. 109–114, 2004.

G. Alexandrakis, E. C. Alfonso, and D. Miller, “Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolones,” Ophthalmology, vol. 107, no. 8, pp. 1497–1502, 2000.

N. A. Chaudhry, H. W. Flynn Jr., T. G. Murray, H. Tabandeh, M. O. Mello Jr., and D. Miller, “Emerging ciprofloxacin-resistant Pseudomonas aeruginosa,” American Journal of Ophthalmology, vol. 128, no. 4, pp. 509–510, 1999.

D. T. H. Tan, C. P. L. Lee, and A. S. M. Lim, “Corneal ulcers in two institutions in Singapore: analysis of causative factors, organisms and antibiotic resistance,” Annals of the Academy of Medicine Singapore, vol. 24, no. 6, pp. 823–829, 1995.

S. J. Tuft and M. Matheson, “In vitro antibiotic resistance in bacterial keratitis in London,” The British Journal of Ophthalmology, vol. 84, no. 7, pp. 687–691, 2000.

K. Srikanth, C. M. Kalavathy, P. A. Thomas, and C. A. N. Jesudasan, “Susceptibility of common ocular bacterial pathogens to antibacterial agents,” Journal of Tamilnadu Ophthalmic Association, vol. 39, no. 1, pp. 49–50, 1998.

G. L. Archer and M. W. Climo, “Antimicrobial susceptibility of coagulase-negative staphylococci,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 10, pp. 2231–2237, 1994.

V. M. Mahajan, “Acute bacterial infections of the eye: their aetiology and treatment,” The British Journal of Ophthalmology, vol. 67, no. 3, pp. 191–194, 1983.

H. M. Leibowitz, “Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis,” American Journal of Ophthalmology, vol. 112, no. 4, pp. 34S–47S, 1991.

D. B. Jones, “Decision-making in the management of microbial keratitis,” Ophthalmology, vol. 88, no. 8, pp. 814–820, 1981.

T. P. O'Brien, M. G. Maguire, N. E. Fink et al., “Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the bacterial keratitis study research group,” Archives of Ophthalmology, vol. 113, no. 10, pp. 1257–1265, 1995.

L. D. Ormerod, “Causes and management of bacterial keratitis in the elderly,” Canadian Journal of Ophthalmology, vol. 24, no. 3, pp. 112–116, 1989.

J. M. Dougherty and J. P. McCulley, “Comparative bacteriology of chronic blepharitis,” The British Journal of Ophthalmology, vol. 68, no. 8, pp. 524–528, 1984.

D. Miller, P. M. Flynn, I. U. Scott, E. C. Alfonso, and H. W. Flynn Jr., “In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates,” Archives of Ophthalmology, vol. 124, no. 4, pp. 479–483, 2006.

T. Agarwal, V. Jhanji, G. Satpathy et al., “Moxifloxacin resistance: intrinsic to antibiotic or related to mutation?” Optometry and Vision Science, vol. 89, no. 12, pp. 1721–1724, 2012.

Centers for Disease Control(CDC) and Prevention, “Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae—Massachusetts, 2001–2006,” Morbidity and Mortality Weekly Report, vol. 56, no. 41, pp. 1077–1080, 2007.

M. McDonald and J. M. Blondeau, “Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones,” Journal of Cataract and Refractive Surgery, vol. 36, no. 9, pp. 1588–1598, 2010.